Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (301-310 of 367) with videos related to

Pageof 37
Sort By:
Thrombosis Research|October 7, 2015
Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patientsDaniela Bianconi, Alexandra Schuler, Clemens Pausz, et al.
Scientific Reports|August 29, 2025
Podoplanin expression is associated with local inflammation and survival in gliomaPegah Mir Seyed Nazari, Maximilian J Mair, Julia Riedl, et al.
Journal of Thrombosis and Haemostasis : JTH|February 20, 2020
Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non-severe haemophilia AJudit Rejtő, Oliver Königsbrügge, Ella Grilz, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2024
Fibrinolysis is impaired in patients with primary immune thrombocytopeniaTheresa Schramm, Jasmin Rast, Dino Mehic, et al.
The Oncologist|September 28, 2017
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)Nicole M Kuderer, Marek S Poniewierski, Eva Culakova, et al.
Journal of Thrombosis and Haemostasis : JTH|June 5, 2025
Clinical evidence for antiglycoprotein IIbIIIa antibody-induced platelet desialylation in primary immune thrombocytopeniaTheresa Schramm, Jan Zlamal, Jasmin Rast, et al.
ESMO Open|May 20, 2020
Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with gliomaPegah Mir Seyed Nazari, Anna S Berghoff, Matthias Preusser, et al.
Blood Advances|January 26, 2021
Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancerYohei Hisada, Kenison B Garratt, Anaum Maqsood, et al.
Blood Advances|June 30, 2022
The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand diseaseCihan Ay, Ingrid Pabinger, Katarina D Kovacevic, et al.
Journal of Thrombosis and Haemostasis : JTH|August 4, 2023
Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before deliveryClaire de Moreuil, Yesim Dargaud, Christophe Nougier, et al.
Pageof 37

Showing results (301-310 of 367) with videos related to

Sort By:
Pageof 37
Thrombosis Research|October 7, 2015
Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patientsDaniela Bianconi, Alexandra Schuler, Clemens Pausz, et al.
Scientific Reports|August 29, 2025
Podoplanin expression is associated with local inflammation and survival in gliomaPegah Mir Seyed Nazari, Maximilian J Mair, Julia Riedl, et al.
Journal of Thrombosis and Haemostasis : JTH|February 20, 2020
Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non-severe haemophilia AJudit Rejtő, Oliver Königsbrügge, Ella Grilz, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2024
Fibrinolysis is impaired in patients with primary immune thrombocytopeniaTheresa Schramm, Jasmin Rast, Dino Mehic, et al.
The Oncologist|September 28, 2017
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)Nicole M Kuderer, Marek S Poniewierski, Eva Culakova, et al.
Journal of Thrombosis and Haemostasis : JTH|June 5, 2025
Clinical evidence for antiglycoprotein IIbIIIa antibody-induced platelet desialylation in primary immune thrombocytopeniaTheresa Schramm, Jan Zlamal, Jasmin Rast, et al.
ESMO Open|May 20, 2020
Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with gliomaPegah Mir Seyed Nazari, Anna S Berghoff, Matthias Preusser, et al.
Blood Advances|January 26, 2021
Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancerYohei Hisada, Kenison B Garratt, Anaum Maqsood, et al.
Blood Advances|June 30, 2022
The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand diseaseCihan Ay, Ingrid Pabinger, Katarina D Kovacevic, et al.
Journal of Thrombosis and Haemostasis : JTH|August 4, 2023
Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before deliveryClaire de Moreuil, Yesim Dargaud, Christophe Nougier, et al.
Pageof 37